Justin M Oldham

University Of California At Davis

$5,034,691

Attributed

$5,034,691

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY2017–25

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,034,691 · 5

By mechanism

R01$3,564,330 · 2

K23$913,680 · 1

R56$399,681 · 1

R03$157,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California At Davis

Same institution · by research overlap

Xiao-Jing Wang$25,575,023
Jing Hong Wang$12,171,384
Pamela J Lein$34,968,069
Keith Bein$1,533,195
Ching-Hsien Chen$1,962,500

Others in their field

Other Emerging Leaders on “Pulmonary Fibrosis”

Jennifer Cohen Price · University Of California, San Francisco$9,253,676
Thomas Dick · Rbhs-New Jersey Medical School$6,611,393
Peter J Leary · University Of Washington$5,643,326
Giovanni Ligresti · Mayo Clinic Rochester$4,830,216
Oliver Eickelberg · University Of Pittsburgh At Pittsburgh$4,701,908
Margaret Louise Salisbury · Vanderbilt University Medical Center$4,266,658

Research focus

Pulmonary FibrosisInterstitial Lung DiseasesInvestigationPulmonary Function DeclineCohortFoundationsPrecision MedicinePhenotypeCessation Of LifeProspectiveClinical TrialsBiologicalIdiopathic Pulmonary FibrosisSamplingCustomFundingMortalityAntifibrotic TreatmentResearch PersonnelBiological MarkersProgressive DiseaseDisease ProgressionClinical Decision-MakingPirfenidone